Program
Presidential Lecture
Thursday, October 13th 13:45-14:15
No.1 (Main Hall, 1F, PACIFICO Yokohama)
Leukemogenesis by RUNX1-EVI1 and afterward stories ~ a message to young doctors and researchers~
Chair | : | Fumimaro Takaku President, The Japanese Association of Medical Sciences |
---|---|---|
Speaker | : | Kinuko Mitani Department of Hematology and Oncology, Dokkyo Medical University School of Medicine |
Special Lecture
Thursday, October 13th 14:15-14:55
No.1 (Main Hall, 1F, PACIFICO Yokohama)
The Non-Coding RNA revolution in biomedical research
Chair | : | Yuzuru Kanakura Department of Hematology & Oncology, Osaka University Graduate School of Medicine |
---|---|---|
Speaker | : | Pier Paolo Pandolfi Genetics, Cancer Center and Cancer Research Institute, Beth Israel Deaconess Medical Center / Harvard Medical School, USA |
ASH Special Lecture
Friday, October 14th 11:20-12:00
No.1 (Main Hall, 1F, PACIFICO Yokohama)
Novel therapies for treating ITP
Chair | : | Shinji Nakao Hematology / Respirology, Faculty of Medicine, Institute of Medicine, Pharmaceutical and Health Sciences, Kanazawa University |
---|---|---|
Speaker | : | Charles Abrams Hematology / Oncology, Department of Medicine, University of Pennsylvania, USA |
EHA Special Lecture
Thursday, October 13th 11:20-12:00
No.1 (Main Hall, 1F, PACIFICO Yokohama)
The myeloproliferative neoplasms - JAK/STAT signalling and stem cell subversion
Chair | : | Itaru Matsumura Department of Hematology & Rheumatology, Kindai University Faculty of Medicine |
---|---|---|
Speaker | : | Tony Green Department of Haematology, University of Cambridge, UK |
JSH Award Lecture
Saturday, October 15th 11:25-12:10
No.1 (Main Hall, 1F, PACIFICO Yokohama)
Chair | : | Koichi Akashi Department of Medicine and Biosystemic Science, Faculty of Medicine, Kyushu University |
---|
Molecular mechanisms that regulate hematopoietic stem cell and its disorder
Speaker | : | Yuzuru Kanakura Department of Hematology & Oncology, Osaka University Graduate School of Medicine |
---|
Presidential Symposium
Thursday, October 13th 15:10-17:20
No.1 (Main Hall, 1F, PACIFICO Yokohama)
Dysregulation of RNA in hematological malignancies
Chairs | : | Koichi Akashi Department of Medicine and Biosystemic Science, Faculty of Medicine, Kyushu University Kinuko Mitani |
---|
Runx1 deficiency decreases ribosome biogenesis and confers stress resistance to hematopoietic stem and progenitor cells
Speaker | : | Nancy A. Speck Abramson Family Cancer Research Institute and Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, USA |
---|
Epigenetic regulation by noncoding RNA
Speaker | : | Daniel G. Tenen Cancer Science Institute of Singapore, Singapore |
---|
Understanding and targeting spliceosomal gene mutations in cancer
Speaker | : | Omar Abdel-Wahab Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, USA |
---|
A novel genetic mechanism of evading anti-tumor immunity in multiple human cancers
Speaker | : | Seishi Ogawa Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University |
---|
JSH-ASH Joint Symposium(Symposium 8)
Saturday, October 15th 9:00-11:10
No.1 (Main Hall, 1F, PACIFICO Yokohama)
Molecular heterogeneity and target therapies of malignant lymphoma in new WHO classification era
Chairs | : | Charles Abrams Hematology / Oncology, Department of Medicine, University of Pennsylvania, USA Tomohiro Kinoshita |
---|
Pathology side: A focused update of the revised WHO classification of lymphoid neoplasms
Speaker | : | Elaine S. Jaffe Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, USA |
---|
Genetic heterogeneity of DLBCL
Speaker | : | Kennosuke Karube Department of Pathology and Cell Biology, Graduate School of Medicine and Faculty of Medicine, University of the Ryukyus |
---|
Progress in the management of ATL
Speaker | : | Kenji Ishitsuka Division of Hematology and Immunology, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University |
---|
Clinical side: New target therapies for malignant lymphoma based on molecular heterogeneity
Speaker | : | Jonathan W. Friedberg University of Rochester, Wilmot Cancer Center, USA |
---|
JSH-EHA Joint Symposium(Symposium 4)
Friday, October 14th 9:00-11:10
No.1 (Main Hall, 1F, PACIFICO Yokohama)
AML with recurrent genetic abnormality in WHO2016
Chairs | : | Tony Green Department of Haematology, University of Cambridge, UK Hitoshi Kiyoi |
---|
Current treatment of acute promyelocytic leukemia
Speaker | : | Miguel A. Sanz Department of Hematology, University Hospital La Fe, Spain |
---|
Pediatric AML with genetic alterations
Speaker | : | Akira Shimada Department of Pediatrics/Pediatric Hematology/Oncology, Okayama Universitry Hospital |
---|
KIT inhibition in core-binding factor
Speaker | : | Peter Paschka Department of Internal Medicine III, University of Ulm, Germany |
---|
Cooperative mutations in AML with recurrent genetic abnormality
Speaker | : | Yuichi Ishikawa Department of Hematology and Oncology, Nagoya University Graduate School of Medicine |
---|
Asian Joint Panel Discussion
Saturday, October 15th 9:00-11:10
No.3 (303, 3F, PACIFICO Yokohama)
Recent progresses in the treatment of immune thrombocytopenia and coagulopathy in Asia
Chairs | : | Sun-Hee Kim Department of Laboratory Medicine, Samsung Medical Center Akitada Ichinose |
---|
Clinical diagnosis and genetics of von Willebrand disease
Speaker | : | Yeu-Chin Chen Hemophilia Care & Research Center / Division of Hematology / Oncology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan |
---|
Challenges in diagnosis and treatment of immune thrombocytopenia (ITP)
Speaker | : | Ponlapat Rojnuckarin Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand |
---|
T cells in the pathogenesis of immune thrombocytopenia
Speaker | : | Hou Ming Department of Hematology, Qilu Hospital, Shandong University, Jinan, China / Shandong Provincial Key Laboratory of Immunohematology, Qilu Hospital, Shandong University, Jinan, China |
---|
Current status of ITP in Korea
Speaker | : | Soo-Mee Bang Seoul National University Bundang Hospital, Seongnam, Korea |
---|
Immune thrombocytopenic purpura: Challenges in management in Indian context
Speaker | : | Manoranjan Mahapatra Department of Hematology, All India Institute of Medical Sciences, New Delhi, India |
---|
Management of direct oral anticoagulant - Associated bleeding
Speaker | : | Lee Lai Heng Singapore General Hospital |
---|
Quick diagnosis for coagulation disorders with prolouged APTT using comprehensive coagulation assays
Speaker | : | Keiji Nogami Department of Pediatrics, Nara Medical University |
---|
Symposium
Symposium 1
Thursday, October 13th 9:00-11:10
No.2 (301+302, 3F, PACIFICO Yokohama)
Transcriptional regulation in hematopoiesis and leukemogenesis
Chairs | : | Hideyo Hirai Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital Shigeru Chiba
|
---|
A single miRNAs rescue transcriptional factor deficiency in B cell lineage specification though TGF beta pathway
Speaker | : | Ai Kotani Devision of Hematological Malignancy Institute of Medical Science, Tokai University |
---|
The transcription factor IRF8 and enhancer landscape dynamics in the development of mononuclear phagocytes
Speaker | : | Tomohiko Tamura Department of Immunology, Yokohama City University Graduate School of Medicine |
---|
Transcriptional and epigenetic dysregulation in pre-leukemic stem cells and their progression to MDS and AML
Speaker | : | Ulrich Steidl Department of Cell Biology, and Medicine (Oncology), Albert Einstein College of Medicine, USA |
---|
Chromosomal rearrangements between 3q21 and 3q26 induce leukemogenesis by misdirecting both EVI1 and GATA2 genes
Speaker | : | Mikiko Suzuki Center for Radioisotope Sciences, Tohoku University Graduate School of Medicine |
---|
Mechanistic insights into aberrant chromatin programming in Leukemia
Speaker | : | Constanze Bonifer Institute for Cancer and Genomic Sciences, University of Birmingham, UK |
---|
Symposium 2
Thursday, October 13th 9:00-11:10
No.12 (501, 5F, PACIFICO Yokohama)
Molecular mechanisms of erythropoiesis - Differentiation, iron metabolism, and eryptosis
Chairs | : | Hiroshi Kawabata Department of Hematology and Immunology, Kanazawa Medical University
Ritsuko Shimizu
|
---|
Transcriptional regulation of erythropoiesis
Speaker | : | Tohru Fujiwara Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine |
---|
Alternative autophagy mediates elimination of mitochondria from embryonic reticulocytes
Speaker | : | Shigeomi Shimizu Department of Pathological Cell Biology, Medical Research Institute, Tokyo Medical and Dental University |
---|
Mechanisms and pathophysiological significance of eryptosis
Speaker | : | Florian Lang Department of Physiology, Eberhard-Karls-University of Tuebingen, Germany |
---|
Identification of erythroferrone and its role in iron metabolism
Speaker | : | Tomas Ganz Department of Medicine, David Geffen School of Medicine, UCLA, USA |
---|
Symposium 3
Thursday, October 13th 15:10-17:20
No.12 (501, 5F, PACIFICO Yokohama)
Advances in tumor immunology
Chairs | : | Kenzaburo Tani Project Division of ALA Advanced Medical Research, The Institute of Medical Science, The University of Tokyo
Norimitsu Kadowaki |
---|
PD-1 blockade for Hodgkin lymphoma
Speaker | : | Stephen M. Ansell Division of Hematology, Mayo Clinic, USA |
---|
Clinical development of immune checkpoint inhibitors and TR research
Speaker | : | Shigehisa Kitano Department of Experimental Therapeutics, National Cancer Center Hospital |
---|
Engineered T cell therapy
Speaker | : | Carlos A. Ramos Center for Cell and Gene Therapy, Hematology/Oncology, Department of Medicine, Baylor College of Medicine, USA |
---|
T-cell receptor repertoire diversity in patients with ATL who receive mogamulizumab
Speaker | : | Ayako Masaki Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences |
---|
Oncolytic Coxsackievirus therapy as an immunostimulator
Speaker | : | Shohei Miyamoto Project Division of ALA Advanced Medical Research, The Institute of Medical Science,The University of Tokyo |
---|
Symposium 5
Friday, October 14th 14:50-17:00
No.1 (Main Hall, 1F, PACIFICO Yokohama)
Clinical aspects and basic research of MDS: Current situation and future
Chairs | : | Mikkael A. Sekeres Leukemia Program, Hematology and Medical Oncology, Cleveland Clinic, USA Mamiko Sakata-Yanagimoto
|
---|
Pre-leukemic hematopoietic stem cells in human acute myeloid leukemia
Speaker | : | Ravi Majeti Medicine - Hematology, Stanford University, USA |
---|
Deregulated polycomb function in the pathogenesis of MDS
Speaker | : | Atsushi Iwama Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University |
---|
Bone marrow failure in childhood: pathological review of nationwide registry
Speaker | : | Masafumi Ito Department of Pathology, Japanese Red Cross, Nagoya 1st. Hospital |
---|
Novel agents in the treatment of myelodysplastic syndromes
Speaker | : | Mikkael A. Sekeres Leukemia Program, Hematology and Medical Oncology, Cleveland Clinic, USA |
---|
Symposium 6
Friday, October 14th 14:50-17:00
No.2 (301+302, 3F, PACIFICO Yokohama)
Cutting edge of stem cell transplantations
Chairs | : | Yoshinobu Maeda Department of Hematology and Oncology, Okayama University Hospital Takehiko Mori |
---|---|---|
Donor cell-derived hematological malignancy
Speaker | : | Motohiro Kato Children's Cancer Center, National Center for Child Health and Development |
---|
Respiratory virus infections in hematopoietic cell transplant recipients
Speaker | : | Sachiko Seo Department of Hematology & Oncology, National Cancer Research Center, East Hospital |
---|
Graft-versus-host disease targets granulosa cell of ovarian follicle and causes infertility after allogeneic hematopoietic stem cell transplantation
Speaker | : | Sonoko Shimoji Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences |
---|
Gut microbiota and graft-versus-host disease – effects of broad-spectrum antibiotic use on microbiota injury after allogeneic hematopoietic stem cell transplantation
Speaker | : | Yusuke Shono Memorial Sloan Kettering Cancer Center, USA |
---|
Novel cytokine and cellular therapy in transplantation
Speaker | : | Geoffrey R. Hill Department of Immunology, QIMR Berghofer Medical Research Institute, Australia |
---|
Symposium 7
Friday, October 14th 9:00-11:10
No.14 (503, 5F, PACIFICO Yokohama)
Guidelines on thrombotic and hemorrhagic diseases
Chairs | : | Tsukasa Ohmori Department of Biochemistry, Jichi Medical University School of Medicine Hidesaku Asakura |
---|
Practical Guide for the management of adult primary immune thrombocytopenia
Speaker | : | Yoshiaki Tomiyama Department of Blood Transfusion, Osaka University Hospital |
---|
Guide for Managing TTP and aHUS
Speaker | : | Hideo Wada Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine |
---|
Congenital and acquired hemophilia
Speaker | : | Satoshi Higasa Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine |
---|
Congenital thormbophilia
Speaker | : | Eriko Morishita Department of Clinical Laboratory Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, USA |
---|
Clinical guidance of venous thromboembolism (VTE)
Speaker | : | Takao Kobayashi Hamamatsu Medical Center |
---|
Symposium 9
Saturday, October 15th 13:20-15:30
No.1 (Main Hall, 1F, PACIFICO Yokohama)
Initial treatment for multiple myeloma: proteasome inhibitor first or immunomodulatory drug first?
Chairs | : | Shinsuke Iida Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences Yasushi Takamatsu |
---|
First-line treatment incorporating proteasome inhibitor for multiple myeloma
Speaker | : | Junya Kuroda Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine |
---|
Clinical trials of IMiD® agents as the first-line therapy of multiple myeloma
Speaker | : | Thierry Facon Lille University Hospital, France |
---|
Clinical trials of proteasome inhibition combined with IMiD in multiple myeloma
Speaker | : | Pieter Sonneveld Department of Hematology, Erasmus MC Cancer Institute, Netherlands |
---|
Combination therapy with monoclonal antibodies for the treatment of newly diagnosed multiple myeloma
Speaker | : | Noriko Nishimura Division of Hematology / Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research |
---|
Treatment algorithm of multiple myeloma in Japan
Speaker | : | Shuji Ozaki Department of Hematology, Tokushima Prefectural Central Hospital |
---|
Symposium 10
Saturday, October 15th 13:20-15:30
No.13 (502, 5F, PACIFICO Yokohama)
Current status and prospects of treatment for adolescent and young adults with hematological malignancies
Chairs | : | Keizo Horibe Clinical Research Center, Nagoya Medical Center Souichi Adachi |
---|
Treatment of ALL in AYA generation: From the viewpoint of pediatric hematologist
Speaker | : | Katsuyoshi Koh Department of Hematology / Oncology, Saitama Children's Medical Center |
---|
Genetic abnormalities of AYA ALL and its treatment strategy by pediatric like protocols
Speaker | : | Fumihiko Hayakawa Department of Hematology and Oncology, Nagoya University Graduate School of Medicine |
---|
Acute myeloid leukemia in adolescents and young adults: from a viewpoint of pediatric hematologist/oncologist
Speaker | : | Daisuke Tomizawa Children's Cancer Center, National Center for Child Health and Development |
---|
AYAs with AML: Perspectives of internal medicine physicians
Speaker | : | Yachiyo Kuwatsuka Center for Advanced Medicine and Clinical Research, Nagoya University Hospital |
---|
Lymphoma of AYA generation: from pediatrician
Speaker | : | Ryoji Kobayashi Department of Pediatrics, Sapporo Hokuyu Hospital |
---|
Adolescent and young adult malignant lymphoma: from a hemato-oncologist’s point of view
Speaker | : | Dai Maruyama Department of Hematology, National Cancer Center Hospital |
---|
Symposium of Women Doctors and Scientists in Hematology
Saturday, October 15th 9:00-11:00
No.13 (502, 5F, PACIFICO Yokohama)
Symposium of Women Doctors and Scientists in Hematology ~women doctors opening a new era~
Chairs | : | Noriko Usui Department of Clinical Oncology and Hematology, The Jikei University Daisan Hospital Masahiro Kizaki |
---|
Origins and evolution of hematologic malignancies
Speaker | : | Mamiko Sakata-Yanagimoto Department of Hematology, Faculty of Medicine, University of Tsukuba |
---|
To achieve safer hematopoietic cell transplantations
Speaker | : | Sachiko Seo Department of Hematology & Oncology, National Cancer Research Center, East Hospital |
---|
Hematopoietic cell transplantation outcome registry and clinical research
Speaker | : | Yoshiko Atsuta The Japanese Data Center for Hematopoietic Cell Transplantation |
---|
Dissecting the pathogenesis of lymphoid malignancies
Speaker | : | Momoko Nishikori Department of Hematology / Oncology, Kyoto University |
---|
Devoting half a life to overcome "lethal" diseases
Speaker | : | Motoko Yamaguchi Department of Hematology and Oncology, Mie University Graduate School of Medicine |
---|
Impact of chromosome translocation in leukemia development
Speaker | : | Mariko Eguchi Department of Pediatrics, Ehime University Graduate School of Medicine |
---|
Plenary Session
Friday, October 14th 13:10-14:40
No.1 (Main Hall, 1F, PACIFICO Yokohama)
Chairs | : | Masahiro Kizaki Department of Hematology, Saitama Medical Center, Saitama Medical University Takanori Teshima |
---|
Novel leukemia stem cell-targeted therapy for AML based on dual inhibition of EZH1/EZH2
Speaker | : | Shuhei Fujita Division of Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan |
---|
The transcriptional and alternative splicing landscape of myelodysplastic syndromes
Speaker | : | Yusuke Shiozawa Department of Pediatrics, Tokyo University, Tokyo, Japan |
---|
Clinical features and prognosis of unselected patients with AML and RAEB-2: JALSG CS07 study
Speaker | : | Yasushi Miyazaki Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan |
---|
The C/EBPβ transcription factor mediates exhaustion of CML stem cells induced by IFNα
Speaker | : | Asumi Yokota Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, Kyoto, Japan |
---|
LGR5+ skin stem cells are targeted in GVHD and topical ruxolitinib protects them against GVHD
Speaker | : | Shuichiro Takahashi Department of Hematology, Hokkaido University Graduate School of Medicine |
---|
New era of platelet biogenesis with a large scale bioreactor optimizing flow and vortex turbulence
Speaker | : | Sou Nakamura Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto |
---|
Educational Lecture / Special Educational Lecture
Educational Lecture 1
Thursday, October 13th 9:00-9:30
No.1 (Main Hall, 1F, PACIFICO Yokohama)
Treatment strategy in untreated transplant-eligible multiple myeloma patients
Chair | : | Akiyoshi Miwa Department of Hematology, National Center for Global Health & Medicine |
---|
Speaker | : | Kazutaka Sunami Department of Hematology, National Hospital Organization Okayama Medical Center |
---|
Educational Lecture 2
Thursday, October 13th 9:30-10:00
No.1 (Main Hall, 1F, PACIFICO Yokohama)
Treatment strategy for transplant-ineligible patients with newly diagnosed multiple myeloma
Chair | : | Yukio Kobayashi Hematology Division, National Cancer Center Hospital |
---|
Speaker | : | Hideto Tamura Division of Hematology,Department of Medicine, Nippon Medical School |
---|
Educational Lecture 3
Thursday, October 13th 10:00-10:30
No.1 (Main Hall, 1F, PACIFICO Yokohama)
Current treatment of refractory and relapsed multiple myeloma
Chair | : | Kenshi Suzuki Japanese Red Cross Medical Center |
---|
Speaker | : | Makoto Sasaki Department of Hematology, Juntendo University School of Medicine |
---|
Special Educational Lecture 4
Thursday, October 13th 10:30-11:10
No.1 (Main Hall, 1F, PACIFICO Yokohama)
Structure-guided research and development of therapeutics for HIV infection & AIDS: Attempts by one hematologist
Chair | : | Keiya Ozawa Division of Genetic Therapeutics, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo |
---|
Speaker | : | Hiroaki Mitsuya National Center for Global Health & Medicine Research Institute, Tokyo, Japan / National Cancer Institute, National Institutes of Health, Bethesda, MD, USA / Kumamoto University School of Medicine Hospital, Kumamoto, Japan |
---|
Educational Lecture 5
Thursday, October 13th 15:10-15:40
No.2 (301+302, 3F, PACIFICO Yokohama)
Clinical manifestation and treatment of extranodal diffuse large B-cell lymphoma
Chair | : | Kunihiro Tsukasaki Department of Hematology, National Cancer Center Hospital East |
---|
Speaker | : | Naoto Tomita Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine |
---|
Educational Lecture 6
Thursday, October 13th 15:40-16:10
No.2 (301+302, 3F, PACIFICO Yokohama)
Progress in the treatment of mature T-cell lymphoma
Chair | : | Kazuo Oshimi Department of Hematology, Kushiro Rosai Hospital |
---|
Speaker | : | Ritsuro Suzuki Department of Oncology and Hematology, Shimane University Cancer Center |
---|
Educational Lecture 7
Thursday, October 13th 16:10-16:40
No.2 (301+302, 3F, PACIFICO Yokohama)
Update on the use of FDG-PET/CT in malignant lymphoma
Chair | : | Koji Izutsu Department of Hematology, Toranomon Hospital |
---|
Speaker | : | Takashi Terauchi Department of Nuclear Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research |
---|
Educational Lecture 8
Thursday, October 13th 16:40-17:10
No.2 (301+302, 3F, PACIFICO Yokohama)
Development of novel combination therapy for lymphoma based on preclinical models
Chair | : | Junji Suzumiya Oncology & Hematology, Shimane University Hospital Cancer Center |
---|
Speaker | : | Owen A. O'Connor Columbia University College of Physicians and Surgeons |
---|
Educational Lecture 9
Thursday, October 13th 9:00-9:30
No.13 (502, 5F, PACIFICO Yokohama)
A primer for epigenetics of hematological malignancies
Chair | : | Mineo Kurokawa Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo |
---|
Speaker | : | Hideaki Nakajima Department of Stem Cell and Immune Regulation Yokohama City University Graduate School of Medicine |
---|
Educational Lecture 10
Thursday, October 13th 9:30-10:00
No.13 (502, 5F, PACIFICO Yokohama)
Self-renewal and differentiation of hematopoietic stem cells
Chair | : | Atsushi Hirao Division of Molecular Genetics, Cancer Research Institute, Kanazawa University |
---|
Speaker | : | Fumio Arai Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University |
---|
Educational Lecture 11
Thursday, October 13th 10:00-10:30
No.13 (502, 5F, PACIFICO Yokohama)
Myeloproliferative neoplasms: updates on molecular pathophysiology, diagnosis and treatment strategies
Chair | : | Norio Komatsu Department of Hematology, Juntendo University School of Medicine |
---|
Speaker | : | Katsuto Takenaka Center for Molecular and Cellular Medicine, Kyushu University Hospital |
---|
Educational Lecture 12
Thursday, October 13th 10:30-11:00
No.13 (502, 5F, PACIFICO Yokohama)
The essence of leukemia stem cells
Chair | : | Toshio Suda National University of Singapore / IRCMS, Kumamoto University |
---|
Speaker | : | Susumu Goyama Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo |
---|
Educational Lecture 13
Thursday, October 13th 15:10-15:40
No.13 (502, 5F, PACIFICO Yokohama)
Von Willebrand factor and von Willebrand disease
Chair | : | Akira Yoshioka Nara Medical University |
---|
Speaker | : | Taei Matsui Faculty of Medical Technology, Fujita Health University School of Health Sciences |
---|
Educational Lecture 14
Thursday, October 13th 15:40-16:10
No.13 (502, 5F, PACIFICO Yokohama)
Spontaneous heparin-induced thrombocytopenia (HIT) syndrome: HIT without any heparin exposure
Chair | : | Mitsuru Murata Department of Laboratory Medicine, Keio University School of Medicine |
---|
Speaker | : | Shigeki Miyata Division of Transfusion Medicine, National Cerebral and Cardiovascular Center |
---|
Educational Lecture 15
Thursday, October 13th 16:10-16:40
No.13 (502, 5F, PACIFICO Yokohama)
Diagnosis and management of DIC complicated by hematological malignancies
Chair | : | Yoichi Sakata Research Division of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University |
---|
Speaker | : | Takayuki Ikezoe Department of Hematology and Respiratory Medicine, Kochi Medical School, Kochi University |
---|
Educational Lecture 16
Thursday, October 13th 16:40-17:10
No.13 (502, 5F, PACIFICO Yokohama)
Exciting investigator-initiated clinical trials
Chair | : | Shuichi Miyawaki Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital |
---|
Speaker | : | Yoshitaka Miyakawa Saitama Medical University |
---|
Educational Lecture 17
Thursday, October 13th 9:00-9:30
No.14 (503, 5F, PACIFICO Yokohama)
The importance of taking late cardiovascular toxicity induced by TKI into consideration in patients with CML
Chair | : | Kazunori Ohnishi Japanese Red Cross Aichi Blood Center |
---|
Speaker | : | Naoto Takahashi Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine |
---|
Educational Lecture 18
Thursday, October 13th 9:30-10:00
No.14 (503, 5F, PACIFICO Yokohama)
Management of advanced-phase chronic myeloid leukemia
Chair | : | Masao Tomonaga Japanese Red Cross Nagasaki Atomic Bomb Hospital |
---|
Speaker | : | Akira Kitanaka Department of Laboratory Medicine, Kawasaki Medical School |
---|
Educational Lecture 19
Thursday, October 13th 10:00-10:30
No.14 (503, 5F, PACIFICO Yokohama)
Molecular pathogenesis of AML
Chair | : | Toshio Kitamura Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo |
---|
Speaker | : | Hiroaki Honda Department of Disease Model, Research Institute for Radiation Biology and Medicine, Hiroshima University |
---|
Educational Lecture 20
Thursday, October 13th 10:30-11:00
No.14 (503, 5F, PACIFICO Yokohama)
Prognostic stratification in the treatment of AML
Chair | : | Ryuzo Ohno Aichi Cancer Center |
---|
Speaker | : | Norio Asou Department of Hematology, International Medical Center, Saitama Medical University |
---|
Educational Lecture 21
Thursday, October 13th 15:10-15:40
No.14 (503, 5F, PACIFICO Yokohama)
Hematopoietic stem cell transplantation for acute myeloid leukemia
Chair | : | Shuichi Taniguchi Department of Hematology, Toranomon Hospital |
---|
Speaker | : | Ken Ishiyama Department of Hematology, Kanazawa University Hospital |
---|
Educational Lecture 22
Thursday, October 13th 15:40-16:10
No.14 (503, 5F, PACIFICO Yokohama)
Treatment of acute myeloid leukemia under relapsed/refractory conditions or in older adults
Chair | : | Takanori Ueda University of Fukui |
---|
Speaker | : | Takahiro Yamauchi Department of Hematology and Oncology, University of Fukui |
---|
Educational Lecture 23
Thursday, October 13th 16:10-16:40
No.14 (503, 5F, PACIFICO Yokohama)
Immune checkpoint inhibitors targeting programmed cell death-1 (PD-1) in cancer therapy
Chair | : | Hiroshi Shiku Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine |
---|
Speaker | : | Kenji Chamoto Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University |
---|
Educational Lecture 24
Thursday, October 13th 16:40-17:10
No.14 (503, 5F, PACIFICO Yokohama)
Direct isolation and application of ultra-pure human mesenchymal stem cells
Chair | : | Tatsutoshi Nakahata Department of Clinical Application, Center for iPS Research and Application (CiRA), Kyoto University |
---|
Speaker | : | Yumi Matsuzaki Department of Life Science, Shimane University Faculty of Medicine |
---|
Educational Lecture 25
Friday, October 14th 9:00-9:30
No.2 (301+302, 3F, PACIFICO Yokohama)
Diffuse large B-cell lymphoma: current standard treatment and future perspectives
Chair | : | Ryuzo Ueda Aichi Medical University School of Medicine |
---|
Speaker | : | Ken Ohmachi Tokai University, School of Medicine, Internal Medicine, Division of Hematology / Oncology |
---|
Educational Lecture 26
Friday, October 14th 9:30-10:00
No.2 (301+302, 3F, PACIFICO Yokohama)
The 2016 WHO Classification of lymphoid neoplasms: revised points
Chair | : | Tomomitsu Hotta National Cancer Center |
---|
Speaker | : | Shigeo Nakamura Department of Pathology and Laboratory Medicine, Nagoya University Hospital |
---|
Educational Lecture 27
Friday, October 14th 10:00-10:30
No.2 (301+302, 3F, PACIFICO Yokohama)
Mechanisms of drug resistance in acute lymphoblastic leukemia
Chair | : | Masafumi Taniwaki Center for Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine |
---|
Speaker | : | Takeshi Inukai Department of Pediatrics, University of Yamanashi |
---|
Special Educational Lecture 28
Friday, October 14th 10:30-11:10
No.2 (301+302, 3F, PACIFICO Yokohama)
How has the management of Ph+ acute lymphoblastic leukemia (ALL) changed over the years
Chair | : | Yasushi Miyazaki Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University |
---|
Speaker | : | Robin Foà Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, “Sapienza” University |
---|
Educational Lecture 29
Friday, October 14th 9:00-9:30
No.12 (501, 5F, PACIFICO Yokohama)
Transfusion medicine in practice
Chair | : | Hideaki Mizoguchi Tokyo Women's Medical University |
---|
Speaker | : | Shigeyoshi Makino Department of Transfusion Medicine, Toranomon Hospital |
---|
Educational Lecture 30
Friday, October 14th 9:30-10:00
No.12 (501, 5F, PACIFICO Yokohama)
Investigation into the identities of circulating exosomes
Chair | : | Tomoki Naoe National Hospital Organization Nagoya Medical Center |
---|
Speaker | : | Takahiro Ochiya Division of Molecular and Cellular Medicine, National Cancer Center Research Institute |
---|
Educational Lecture 31
Friday, October 14th 10:00-10:30
No.12 (501, 5F, PACIFICO Yokohama)
Hepcidin
Chair | : | Hideo Harigae Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine |
---|
Speaker | : | Tomas Ganz David Geffen School of Medicine, UCLA, USA |
---|
Special Educational Lecture 32
Friday, October 14th 10:30-11:10
No.12 (501, 5F, PACIFICO Yokohama)
Diagnosis and treatment of HLH in adults
Chair | : | Masaki Yasukawa Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine |
---|
Speaker | : | Nancy Berliner Division of Hematology, Brigham and Women's Hospital Medicine, Harvard Medical School |
---|
Educational Lecture 33
Friday, October 14th 14:50-15:20
No.12 (501, 5F, PACIFICO Yokohama)
Diagnostics for multiple myeloma
Chair | : | Hirokazu Murakami Gunma University Graduate School of Health Sciences |
---|
Speaker | : | Etsuko Yamazaki Clinical Laboratory Department, Yokohama City University Hospital |
---|
Educational Lecture 34
Friday, October 14th 15:20-15:50
No.12 (501, 5F, PACIFICO Yokohama)
Treatment strategy of MGUS and smoldering multiple myeloma
Chair | : | Masayuki Hino Hematology, Osaka City University |
---|
Speaker | : | Masuzu Ueda Department of Clinical Oncology and Division of Hematology, Department of Medicine, Jichi Medical University |
---|
Educational Lecture 35
Friday, October 14th 15:50-16:20
No.12 (501, 5F, PACIFICO Yokohama)
Multiple myeloma: progress in management aimed at improving QoL
Chair | : | Akira Miura Social Welfare Corporation Keijinkai / National University Corporation, Akita University |
---|
Speaker | : | Masahiro Abe Tokushima University Graduate School, Department of Hematology, Endocrinology and Metabolism Medicine and Bioregulatory Sciences |
---|
Educational Lecture 36
Friday, October 14th 16:20-16:50
No.12 (501, 5F, PACIFICO Yokohama)
Functional contribution of oxidative stress response to differentiation and proliferation of hematopoietic cells
Chair | : | Kazuo Motoyoshi National Defense Medical College |
---|
Speaker | : | Hozumi Motohashi Department of Gene Expression Regulation in Institute of Development, Aging and Cancer, Tohoku University |
---|
Educational Lecture 37
Friday, October 14th 9:00-9:30
No.13 (502, 5F, PACIFICO Yokohama)
Iron deficiency anemia refractory to iron preparations
Chair | : | Akio Urabe NTT Medical Center Tokyo |
---|
Speaker | : | Takahiro Suzuki Division of Hematology, Department of Medicine, Jichi Medical University |
---|
Educational Lecture 38
Friday, October 14th 9:30-10:00
No.13 (502, 5F, PACIFICO Yokohama)
Aplastic anemia
Chair | : | Yutaka Kohgo International University of Health and Welfare Hospital |
---|
Speaker | : | Kensuke Usuki Department of Hematology, Medical Center Tokyo |
---|
Educational Lecture 39
Friday, October 14th 10:00-10:30
No.13 (502, 5F, PACIFICO Yokohama)
Pathogenesis of paroxysmal nocturnal hemoglobinuria
Chair | : | Mitsuhiro Omine Showa University Fujigaoka Hospital |
---|
Speaker | : | Yoshiko Murakami Research Institute for Microbial Diseases, Osaka University |
---|
Educational Lecture 40
Friday, October 14th 10:30-11:00
No.13 (502, 5F, PACIFICO Yokohama)
Genetic diagnosis for congenital hemolytic anemia
Chair | : | Kazuo Dan Faculty of Health Science, Ryotokuji University |
---|
Speaker | : | Shouichi Ohga Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University |
---|
Educational Lecture 41
Friday, October 14th 14:50-15:20
No.13 (502, 5F, PACIFICO Yokohama)
A novel disease entity; TAFRO syndrome
Chair | : | Toshiko Motoji Tokyo Women's Medical University |
---|
Speaker | : | Yasufumi Masaki Hematology and Immunology, Medicine, Kanazawa Medical University |
---|
Educational Lecture 42
Friday, October 14th 15:20-15:50
No.13 (502, 5F, PACIFICO Yokohama)
Targeted therapies for Hodgkin lymphoma: results of recent trials
Chair | : | Kiyohiko Hatake Department of Hematology Oncology, Cancer Institute Hospital, Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research |
---|
Speaker | : | Fredrick B. Hagemeister Department of Lymphoma / Myeloma, MD Anderson Cancer Center |
---|
Educational Lecture 43
Friday, October 14th 15:50-16:20
No.13 (502, 5F, PACIFICO Yokohama)
Targeting immune checkpoints in lymphoma
Chair | : | Mitsune Tanimoto Department of Hematology and Oncology, Okayama University |
---|
Speaker | : | Stephen M. Ansell Mayo Clinic |
---|
Special Educational Lecture 44
Friday, October 14th 16:20-17:00
No.13 (502, 5F, PACIFICO Yokohama)
Targeting apoptotic pathways to treat lymphoid malignancies
Chair | : | Kensei Tobinai Department of Hematology, National Cancer Center Hospital |
---|
Speaker | : | Andrew W. Roberts Department of Clinical Hematology and Bone Marrow Transplantation, The Royal Melbourne Hospital, Parkville, Victoria, Australia / Cancer and Haematology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia / Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia / Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia |
---|
Educational Lecture 45
Friday, October 14th 14:50-15:20
No.14 (503, 5F, PACIFICO Yokohama)
How to choose and understand clinical laboratory tests in daily clinical management of hematologic diseases
Chair | : | Tadashi Matsushita Department of Transfusion Medicine, Nagoya University Hospital |
---|
Speaker | : | Yoshinobu Seki Department of Hematology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital |
---|
Educational Lecture 46
Friday, October 14th 15:20-15:50
No.14 (503, 5F, PACIFICO Yokohama)
Rare bleeding disorders: diagnosis of platelet function disorder
Chair | : | Yukio Ozaki Fuefuki Chuo Hospital |
---|
Speaker | : | Hisashi Kato Department of Hematology and Oncology, Osaka University Graduate School of Medicine |
---|
Educational Lecture 47
Friday, October 14th 15:50-16:20
No.14 (503, 5F, PACIFICO Yokohama)
Trends in novel treatments for hemophilia
Chair | : | Eiichi Ishii Department of Pediatrics, Ehime University Graduate School of Medicine |
---|
Speaker | : | Midori Shima Department of Pediatrics, Nara Medical University |
---|
Educational Lecture 48
Friday, October 14th 16:20-16:50
No.14 (503, 5F, PACIFICO Yokohama)
Epstein-Barr virus infection and related hematological diseases
Chair | : | Naoyuki Katayama Department of Hematology and Oncology, Mie University Graduate School of Medicine |
---|
Speaker | : | Akihisa Sawada Osaka Medical Center and Research Institute for Maternal and Child Health, Hematology / Oncology |
---|
Educational Lecture 49
Saturday, October 15th 9:00-9:30
No.2 (301+302, 3F, PACIFICO Yokohama)
Historical perspectives and future directions of gene-modified T-cell therapy
Chair | : | Arinobu Tojo Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo |
---|
Speaker | : | Yoshiki Akatsuka Department of Hematology, Fujita Health University School of Medicine / Division of Immunology, Aichi Cancer Center Research Institute |
---|
Educational Lecture 50
Saturday, October 15th 9:30-10:00
No.2 (301+302, 3F, PACIFICO Yokohama)
Recent insights to the mechanisms of graft-versus-host disease
Chair | : | Shinichiro Okamoto Division of Hematology, Keio Universiy School of Medicine |
---|
Speaker | : | Geoffrey R. Hill QIMR Berghofer Medical Research Institute, Department of Bone Marrow Transplantation, Royal Brisbane and Women’s Hospital |
---|
Educational Lecture 51
Saturday, October 15th 10:00-10:30
No.2 (301+302, 3F, PACIFICO Yokohama)
Treatment of acute graft-versus-host disease
Chair | : | Yoshinobu Kanda Division of Hematology, Department of Medicine, Jichi Medical University |
---|
Speaker | : | Makoto Murata Department of Hematology and Oncology, Nagoya University Graduate School of Medicine |
---|
Special Educational Lecture 52
Saturday, October 15th 10:30-11:10
No.2 (301+302, 3F, PACIFICO Yokohama)
Update on stem cell transplantation for acute leukemias
Chair | : | Mine Harada Medical Center for Karatsu-Higashimatsuura Medical Association |
---|
Speaker | : | Shin Mineishi Blood and Marrow Transplant Program, Penn State Hershey Medical Center |
---|
Educational Lecture 53
Saturday, October 15th 13:20-13:50
No.2 (301+302, 3F, PACIFICO Yokohama)
How does HTLV-1 induce ATL?
Chair | : | Akifumi Takaori-Kondo Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University |
---|
Speaker | : | Masao Matsuoka Institute for Virus Research, Kyoto University |
---|
Educational Lecture 54
Saturday, October 15th 13:50-14:20
No.2 (301+302, 3F, PACIFICO Yokohama)
Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma
Chair | : | Tatsuo Ichinohe Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University |
---|
Speaker | : | Atae Utsunomiya Department of Hematology, Imamura bun-in Hospital |
---|
Educational Lecture 55
Saturday, October 15th 14:20-14:50
No.2 (301+302, 3F, PACIFICO Yokohama)
HTLV-1-targeted immunotherapy
Chair | : | Yutaka Kawakami Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine |
---|
Speaker | : | Youko Suehiro Department of Hematology, Department of Cell Therapy, National Kyushu Cancer Center |
---|
Educational Lecture 56
Saturday, October 15th 14:50-15:20
No.2 (301+302, 3F, PACIFICO Yokohama)
Allogeneic hematopoietic stem cell transplantation for inherited diseases
Chair | : | Koji Nagafuji Division of Hematology & Oncology, Department of Medicine, Kurume University School of Medicine |
---|
Speaker | : | Hiromasa Yabe Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine |
---|
Educational Lecture 57
Saturday, October 15th 9:00-9:30
No.14 (503, 5F, PACIFICO Yokohama)
Ethics for clinical research
Chair | : | Shigetaka Asano Waseda University |
---|
Speaker | : | Taira Maekawa Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital |
---|
Educational Lecture 58
Saturday, October 15th 9:30-10:00
No.14 (503, 5F, PACIFICO Yokohama)
Primary immunodeficiency disease and hematology
Chair | : | Masao Kobayashi Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences |
---|
Speaker | : | Hirokazu Kanegane Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University |
---|
Educational Lecture 59
Saturday, October 15th 10:00-10:30
No.14 (503, 5F, PACIFICO Yokohama)
Childhood lymphoma
Chair | : | Yasuhide Hayashi Japanese Red Cross Gunma Blood Center |
---|
Speaker | : | Tetsuya Mori Department of Pediatrics, St. Marianna University School of Medicine |
---|
Educational Lecture 60
Saturday, October 15th 10:30-11:00
No.14 (503, 5F, PACIFICO Yokohama)
Genetic and epigenetic aberrations of pediatric leukemia and clinical applications
Chair | : | Etsuro Ito Department of Pediatrics, Hirosaki University Graduate School of Medicine |
---|
Speaker | : | Junko Takita The University of Tokyo, Graduate School of Medicine, Department of Pediatrics |
---|
Educational Lecture 61
Saturday, October 15th 13:20-13:50
No.14 (503, 5F, PACIFICO Yokohama)
Basics and applications of genome editing technology
Chair | : | Shuki Mizutani Tokyo Medical & Dental University / Kawasaki North Developmental Center |
---|
Speaker | : | Takashi Yamamoto Molecular Genetics Laboratory, Department of Mathematical and Life Sciences, Graduate School of Science, Hirosima University |
---|
Educational Lecture 62
Saturday, October 15th 13:50-14:20
No.14 (503, 5F, PACIFICO Yokohama)
Pathophysiology of MDS: genomic aberrations
Chair | : | Kazuya Shimoda Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki |
---|
Speaker | : | Motoshi Ichikawa Department of Hematology and Oncology, Dokkyo Medical University |
---|
Educational Lecture 63
Saturday, October 15th 14:20-14:50
No.14 (503, 5F, PACIFICO Yokohama)
Progress in the diagnosis of and therapy for MDS
Chair | : | Kazuma Ohyashiki Department of Hematology, Tokyo Medical University |
---|
Speaker | : | Yasuhito Nannya Kyoto University, Department of Pathology and Tumor Biology |
---|
Educational Lecture 64
Saturday, October 15th 14:50-15:20
No.14 (503, 5F, PACIFICO Yokohama)
Prophylactic strategies for invasive fungal infections after allogeneic hematopoietic stem cell transplantation
Chair | : | Yoji Ishida Hematology and Oncology, Internal Medicine, Iwate Medical University School of Medicine |
---|
Speaker | : | Yuki Asano-Mori Department of Hematology, Toranomon Hospital |
---|
Corporate Seminar
Thursday, October 13th 12:15ー13:00
LS1-2. The Role of Bruton Tyrosine Kinase Inhibitor in the Management of Relapsed and Refractory Chronic Lymphocytic Leukemia
No.2 (301+302, 3F, PACIFICO Yokohama)
Chair | : | Junji Suzumiya Shimane University Hospital Cancer Center |
---|---|---|
Speaker | : | Paolo Ghia Università Vita-Salute and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy |
Sponsor | : | Janssen Pharmaceutical K.K. |
LS1-3. Optimizing ET Treatment
No.3 (303, 3F, PACIFICO Yokohama)
Chair | : |
Norio Komatsu Department of Hematology, Juntendo University School of Medicine |
---|---|---|
Speaker | : | Jean-Jacques KILADJIAN Clinical Investigations Center, Saint-Louis Hospital - Paris Diderot University |
Sponsor | : | Shire Japan KK |
LS1-4. The Rapidly Changing Landscape of PTCL Management
No.4 (304, 3F, PACIFICO Yokohama)
Chair | : |
Kensei Tobinai National Cancer Center |
---|---|---|
Speaker | : | Owen O’Connor Columbia University |
Sponsor | : | Mundipharma K.K. |
LS1-5. Ph+ ALL. The GIMEMA experience with TKI
No.5 (311+312, 3F, PACIFICO Yokohama)
Chair | : |
Yuzuru Kanakura Osaka University Graduate School of Medicine |
---|---|---|
Speaker | : | Robin Foà Department of Cellular Biotechnologies and Hematology Policlinico Umberto I“― Sapienza”University |
Sponsor | : | Bristol-Myers Squibb K.K. |
Friday, October 14th 12:15ー13:00
LS2-2. The role and the potential benefits of rATG in allogeneic stem cell transplantation
No.2 (301+302, 3F, PACIFICO Yokohama)
Chair | : |
Shuichi Taniguchi Department of Hematology, Toranomon Hospital |
---|---|---|
Speaker | : | Mohamad Mohty Department of Hematology, Hematology and cellular therapy Department, Hospital Saint-Antoine, and University Pierre & Marie Curie, Paris, France |
Sponsor | : | Sanofi K.K. |
LS2-3. Updates in the treatment of lower-risk MDS
No.3 (303, 3F, PACIFICO Yokohama)
Chair | : |
Yasushi Miyazaki Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University |
---|---|---|
Speaker | : | Mikkael Sekeres Hematology and Oncology Cleveland Clinic |
Sponsor | : | Kyowa Hakko Kirin Co., Ltd. |
LS2-4. The current positioning of proteasome inhibitor in the treatment strategy of multiple myeloma
No.4 (304, 3F, PACIFICO Yokohama)
Chair | : |
Itaru Matsumura Division of Hematology, Department of Internal Medicine, Kindai University School of Medicine |
---|---|---|
Speaker | : | Pieter Sonneveld Erasmus MC Cancer Institute Rotterdam The Netherlands |
Sponsor | : | Janssen Pharmaceutical K.K. / Takeda Pharmaceutical Company Limited. |
LS2-17. New standards of care for NDMM ―patients not eligible for transplant―
No.17 (Cannes & Nice, 3F, InterContinental Yokohama Grand)
Chair | : |
Masahiro Abe The University of Tokushima Graduate School Institute of Health Biosciences, Department of Medicine and Bioregulatory Sciences |
---|---|---|
Speaker | : | Thierry Facon CHRU de Lille ―Hôpital Claude Huriez Rue Michel Polonovski, France |
Sponsor | : | Celgene K.K. |
Saturday, October 15th 8:00ー8:45
MS3-4. Mantle cell lymphoma; Molecular pathogenesis and prognostic factors
No.4 (304, 3F, PACIFICO Yokohama)
Chair | : |
Hirokazu Nagai Department of Hematology / Oncology Research, Clinical Research Center NationalHospital Organization, Nagoya Medical Center |
---|---|---|
Speaker | : | Simon Rule Derriford Hospital, Plymouth, United Kingdom |
Sponsor | : | Janssen Pharmaceutical K.K. |
Saturday, October 15th 12:25ー13:10
LS3-2. New treatment paradigm for B-cell malignancies
No.2 (301+302, 3F, PACIFICO Yokohama)
Chair | : |
Kiyohiko Hatake Cancer Institute Hospital |
---|---|---|
Speaker | : | John Seymour The Peter MacCallum Cancer Centre |
Sponsor | : | AbbVie GK |
LS3-5. Developing a Molecularly Targeted Therapy Approach to Multiple Myeloma
No.5 (311+312, 3F, PACIFICO Yokohama)
Chair | : |
Kazuyuki Shimizu National Hospital Organization Higashinagoya National Hospital |
---|---|---|
Speaker | : | Robert Z. Orlowski The University of Texas MD Anderson Cancer Center |
Sponsor | : | Fujimoto Pharmaceutical Corp. |
LS3-8. Treatment Strategy to Low-grade B-cell Lymphoma
No.8 (413, 4F, PACIFICO Yokohama)
Chair | : |
Tomohiro Kinoshita Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital |
---|---|---|
Speaker | : | Jonathan W. Friedberg University of Rochester Wilmot Cancer Center, USA |
Sponsor | : | SymBio Pharmaceuticals Limited / Eisai Co., Ltd. |
LS3-11. The Emerging Role of HDAC Inhibitors in the New Era of Relapse and Refractory Multiple Myeloma Treatment
No.11 (419, 4F, PACIFICO Yokohama)
Chair | : |
Chiaki Nakaseko Department of Hematology, Chiba University Hospital |
---|---|---|
Speaker | : | Paul G. Richardson Dana-Farber Cancer Institute, Boston, USA |
Sponsor | : | Novartis Pharma K.K. |
LS3-12. Do we have to eradicate CML stem cells or to achieve a deep molecular response ?
No.12 (501, 5F, PACIFICO Yokohama)
Chair | : |
Koichi Miyamura Department of Hematology, Japanese Red Cross Nagoya Daiichi Hospital |
---|---|---|
Speaker | : | Philippe Rousselot University of Versailles St-Quentin-en-Yvelines, Versailles, France |
Sponsor | : | Novartis Pharma K.K. |
LS3-14. Future Direction of Folicular Lymphoma treatment based on MDACC experience and analysis
No.14 (503, 5F, PACIFICO Yokohama)
Chair | : |
Tsukasaki Kunihiro Department of Hematology, National Cancer Center Hospital East |
---|---|---|
Speaker | : | Fredrick B. Hagemeister Internist and Professor of Medicine, Department of Lymphoma / Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX |
Sponsor | : | Chugai Pharmaceutical Co., Ltd. |